North America Aorto-iliac Occlusive Disease Treatment Market Size & Outlook
Related Markets
North America aorto-iliac occlusive disease treatment market highlights
- The North America aorto-iliac occlusive disease treatment market generated a revenue of USD 984.3 million in 2025.
- The market is expected to grow at a CAGR of 4.8% from 2026 to 2033.
- In terms of segment, endovascular devices was the largest revenue generating device type in 2025.
- Endovascular Devices is the most lucrative device type segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 984.3 million |
| Market revenue in 2033 | USD 1,433.0 million |
| Growth rate | 4.8% (CAGR from 2026 to 2033) |
| Largest segment | Endovascular devices |
| Fastest growing segment | Endovascular Devices |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Endovascular Devices, Surgical Devices |
| Key market players worldwide | BD, Bentley, Scitech Medical, Abbott, Boston Scientific Corp, W.L. Gore & Associates, Medtronic PLC, COOK, Terumo Corp, iVascular, Getinge AB ADR, Biotronik SE & Co., KG |
Other key industry trends
- In terms of revenue, North America region accounted for 43.5% of the global aorto-iliac occlusive disease treatment market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 800.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aorto-Iliac Occlusive Disease Treatment Market Scope
Aorto-Iliac Occlusive Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Scitech Medical | View profile | 101-250 | Goiânia, Goias, Brazil, South America | https://www.scitechmed.com/ |
| Bentley | View profile | 251-500 | Hechingen, Baden-Wurttemberg, Germany, Europe | https://bentley.global |
| Biotronik SE & Co., KG | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| COOK | View profile | 1001-5000 | Sittingbourne, Kent, United Kingdom, Europe | https://www.cookfood.net/ |
| iVascular | View profile | 51-100 | Barcelona, Catalonia, Spain, Europe | http://www.ivascular.global/ |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| W.L. Gore & Associates | View profile | 5001-10000 | Newark, New Jersey, United States, North America | http://www.gore.com |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
| Getinge AB ADR | View profile | 11862 | Lindholmspiren 7A, P.O. Box 8861, Gothenburg, Sweden, SE-417 56 | https://www.getinge.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
North America aorto-iliac occlusive disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aorto-iliac occlusive disease treatment market will help companies and investors design strategic landscapes.
Endovascular devices was the largest segment with a revenue share of 92.41% in 2025. Horizon Databook has segmented the North America aorto-iliac occlusive disease treatment market based on endovascular devices, surgical devices covering the revenue growth of each sub-segment from 2021 to 2033.
North America dominated the aortoiliac occlusive disease (iliac disease) treatment market, with a share of 43.5% in 2024. The rising incidence of PAD, increased government initiatives, and technological advancements drive the market's growth. According to the Science Direct article published in March 2025, it is estimated that around 6.5 million individuals aged 40 years and above are affected, representing approximately 5.8% of this population group.
Additionally, the annual incidence rate of PAD is approximately 2.69%, reflecting the steady rise in new cases each year. These trends highlight the increasing need for effective diagnostic and treatment solutions in the U.S. aorto-iliac occlusive disease treatment market, as healthcare systems work to address the complications and risks associated with age-related vascular conditions.
Reasons to subscribe to North America aorto-iliac occlusive disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America aorto-iliac occlusive disease treatment market databook
-
Our clientele includes a mix of aorto-iliac occlusive disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America aorto-iliac occlusive disease treatment market , including forecasts for subscribers. This continent databook contains high-level insights into North America aorto-iliac occlusive disease treatment market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
North America aorto-iliac occlusive disease treatment market size, by country, 2021-2033 (US$M)
North America Aorto-Iliac Occlusive Disease Treatment Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
